OR WAIT null SECS
April 16, 2020
Biopharmaceutical company, TScan Therapeutics, has entered into a collaboration agreement with Novartis that is aimed at the discovery and development of novel T-cell receptor (TCR) therapies for solid tumors.
The guidance document describes the agency’s temporary policy for the compounding of drugs during the COVID-19 pandemic.
The company is recalling three lots of Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL) due to potential N-Nitrosodimethylamine (NDMA) contamination.
Experts to discuss strategies for ensuring supply of quality drug products during a pandemic in April 28 online event.
April 15, 2020
AstraZeneca has announced it will be commencing a randomized, global clinical trial to assess the efficacy and safety of Calquence (acalabrutinib) in treating the exaggerated immune response of patients with COVID-19.
Sanofi and GlaxoSmithKline (GSK) have revealed that they are joining forces to develop an adjuvanted vaccine using their respective technologies that can be used to fight COVID-19.
ISPE’s Facility of the Year Awards for 2020 go to bio/pharma companies in eight award categories, including two winners in the new Social Impact category.
The agency sent warning letters to three more companies for selling unapproved products claiming to treat COVID-19.
April 13, 2020
Drug manufacturers, distributors, and dispensers oppose Buy American policies as likely to reduce reliable supplies and raise product costs.
April 10, 2020
The task force will assist in the developing, authorizing, and monitoring of treatments of COVID-19.